Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

…, JT Merrill, PR Fortin, IN Bruce, D Isenberg… - Arthritis & …, 2012 - Wiley Online Library
… Ian Bruce and David Isenberg, allowed intense discussions of the criteria deficiencies.
Cases that were misclassified by the rule were used to stimulate discussions regarding how the …

[PDF][PDF] CD19+ CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients

…, LY Noreña, F Flores-Borja, DJ Rawlings, DA Isenberg… - immunity, 2010 - cell.com
The immunosuppressive function of regulatory B cells has been shown in several murine
models of chronic inflammation, including collagen-induced arthritis, inflammatory bowel …

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis

…, MA Dooley, EM Ginzler, D Isenberg… - Journal of the …, 2009 - journals.lww.com
Recent studies have suggested that mycophenolate mofetil (MMF) may offer advantages
over intravenous cyclophosphamide (IVC) for the treatment of lupus nephritis, but these …

Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community

…, PY Hatron, EM Hay, DA Isenberg… - … : Official Journal of …, 1993 - Wiley Online Library
Objective. Different sets of diagnostic criteria have been proposed for Sjögren's syndrome (SS),
but none have been validated with a large series of patients or in a multicenter study. We …

Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: the randomized, double‐blind, phase II/III systemic lupus …

…, TO Utset, C Gordon, DA Isenberg… - … : Official Journal of …, 2010 - Wiley Online Library
Objective B cells are likely to contribute to the pathogenesis of systemic lupus erythematosus
(SLE), and rituximab induces depletion of B cells. The Exploratory Phase II/III SLE …

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus …

…, E Hay, D Symmons, D Isenberg… - … : Official Journal of …, 1996 - Wiley Online Library
Objective. To develop and perform an initial validation of a damage index for systemic lupus
erythematosus (SLE). Methods. A list of items considered to reflect damage in SLE was …

Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy

…, A Singh, S Moore, G Warnes, DA Isenberg… - The Journal of …, 2004 - rupress.org
Regulatory T cells have been clearly implicated in the control of disease in murine models
of autoimmunity. The paucity of data regarding the role of these lymphocytes in human …

[HTML][HTML] Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) …

…, FA Houssiau, JPA Ioannidis, DA Isenberg… - Annals of the …, 2012 - ard.bmj.com
Objectives To develop recommendations for the management of adult and paediatric lupus
nephritis (LN). Methods The available evidence was systematically reviewed using the …

Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis

…, D Jayne, EM Ginzler, D Isenberg… - … England Journal of …, 2011 - Mass Medical Soc
Background Maintenance therapy, often with azathioprine or mycophenolate mofetil, is
required to consolidate remission and prevent relapse after the initial control of lupus nephritis. …

Treat-to-target in systemic lupus erythematosus: recommendations from an international task force

…, M Mosca, G Bertsias, D Isenberg… - Annals of the …, 2014 - ard.bmj.com
The principle of treating-to-target has been successfully applied to many diseases outside
rheumatology and more recently to rheumatoid arthritis. Identifying appropriate therapeutic …